[Thrombosing disease in the course of a lupic syndrome revealed by an estroprogestational agent].
D000328:Adult; D000925:Anticoagulants / Q000627:therapeutic use; D001018:Aortic Diseases / Q000209:etiology*; D003276:Contraceptives, Oral / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007083:Iliac Artery; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy; D011241:Prednisone / Q000627:therapeutic use; D011247:Pregnancy; D011248:Pregnancy Complications; D011655:Pulmonary Embolism / Q000209:etiology*; D013924:Thrombophlebitis / Q000209:etiology; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D003276:Contraceptives, Oral; D011241:Prednisone
Maladie thrombosante au cours d'un syndrome lupique révélé par un oestroprogestatif.